Amgen
Biotechnology.
Based in CA
🤖
AI Overview
With $920K in lobbying spend across 17 quarterly filings, Amgen is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2022 to 2025.
$920K
Total Spend
4
Years Active
1
Firms Hired
5
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $200K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Medicare/Medicaid, Government Issues, Budget/Appropriations and 1 more
- •Prescription drug reimbursement. General tax issues.
- •Monitored S. 3799, PREVENT Pandemics Act. Monitored issues related to FDA user fee agreements. Issues regarding timely access to medications.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.